Tokyo, Japan

Madoka Kawamura

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 6.9

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • Saitama, JP (2012)
  • Toshima-ku, JP (2012 - 2013)
  • Tokyo, JP (2013 - 2022)

Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Madoka Kawamura: Innovator in Pharmaceutical Chemistry

Introduction

Madoka Kawamura is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address various health issues. With a total of 5 patents to her name, Kawamura's work has the potential to impact many lives.

Latest Patents

Kawamura's latest patents include a pyridine compound substituted with azole, which has shown an inhibitory effect on the 20-HETE producing enzyme. This compound is represented by a specific formula and is designed to be a pharmaceutically acceptable salt. Another notable patent is a 7-piperidinoalkyl-3, 4-dihydroquinolone derivative. This compound aims to provide solutions for a range of mental health disorders, including depression, anxiety disorders, and cognitive impairments, among others.

Career Highlights

Throughout her career, Kawamura has worked with reputable companies such as Taisho Pharmaceutical Co., Ltd. and Meiji Seika Kaisha, Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to innovative pharmaceutical solutions.

Collaborations

Kawamura has collaborated with notable coworkers, including Haruhisa Ogita and Masato Kashimura. These partnerships have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Madoka Kawamura's contributions to pharmaceutical chemistry through her innovative patents demonstrate her commitment to improving health outcomes. Her work continues to pave the way for advancements in the treatment of various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…